Guardant Health files Rule 144 to sell 40,000 shares

Guardant Health, Inc. submitted a Rule 144 notice for the proposed sale of 40,000 common shares on 03/04/2026.

Rhea-AI Filing Summary

Guardant Health, Inc. submitted a Rule 144 notice for the proposed sale of 40,000 common shares on 03/04/2026. The filing lists Charles Schwab & Co., Inc. as the broker and identifies the method as a Broker Payment for Cashless Exercise.

An earlier sale by Kumud Kalia of 2,000 shares on 12/08/2025 for $209,204.00 is reported as securities sold during the past three months.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health's Rule 144 filing (GH) state?

The filing states a proposed sale of 40,000 common shares on 03/04/2026, using Charles Schwab & Co., Inc. and described as a Broker Payment for Cashless Exercise.

Who is the broker listed in the GH Form 144?

The broker listed is Charles Schwab & Co., Inc. with an address shown as 3000 Schwab Way, Westlake, TX 76262, associated with the proposed sale of 40,000 common shares on 03/04/2026.

Does the filing show recent insider sales for GH?

Yes. The filing reports a prior sale by Kumud Kalia of 2,000 shares on 12/08/2025 for $209,204.00, listed under securities sold during the past three months.

What method is specified for the proposed GH share disposition?

The method specified is a Broker Payment for Cashless Exercise, indicating the sale is tied to an option exercise and handled through a broker, as listed for the 03/04/2026 transaction.

Is the Form 144 filing for GH indicative of company-issued shares or insider resale?

The filing lists a proposed resale of 40,000 common shares by an individual via Rule 144; it identifies broker-assisted cashless exercise as the method, consistent with an insider transaction rather than a primary offering.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:06 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001927831
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Kalia Kumud
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	40000	3812660.00	131170441	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2026	Employee Stock Option Exercise	Guardant Health, Inc.			40000	03/04/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KUMUD KALIA 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	12/08/2025	2000	209204.00

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	KUMUD KALIA
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)